LG002 (uncellularised)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LG002 (uncellularised), covering 2010-01-21 to 2010-01-21. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Tolerance of Cellularised LG002 Versus Uncellularised LG002 in the Treatment of Severe Burns Injuries [Phase 2]